2-piperidone has been researched along with Basal Ganglia Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baro, F; Dom, R; Van Lommel, R | 2 |
2 trial(s) available for 2-piperidone and Basal Ganglia Diseases
| Article | Year |
|---|---|
Dexetimide: an effective drug for the control of extrapyramidal symptoms induced by pipothiazine palmitate.
Topics: Administration, Oral; Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Benzyl Compounds; Delayed-Action Preparations; Drug Evaluation; Humans; Injections, Intramuscular; Male; Middle Aged; Palmitic Acids; Phenothiazines; Piperidines; Piperidones; Placebos; Psychotic Disorders; Remission, Spontaneous; Sulfonamides | 1973 |
A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent.
Topics: Administration, Oral; Adult; Antiparkinson Agents; Basal Ganglia Diseases; Benztropine; Benzyl Compounds; Clinical Trials as Topic; Delayed-Action Preparations; Evaluation Studies as Topic; Haloperidol; Humans; Injections, Intramuscular; Intraocular Pressure; Male; Middle Aged; Movement Disorders; Parasympatholytics; Piperidines; Piperidones; Placebos; Psychotic Disorders; Tropanes | 1971 |